Sarah Mathieson | Senior Vice President-Corporate Affairs |
David Cory | President & Chief Executive Officer |
Ingrid Choong | Senior Vice President-Clinical Development |
Eldon Mayer | Chief Commercial Officer |
Sri Ryali | Chief Financial Officer |
Colleen Craig | Vice President-Metabolic Diseases |
Ashik Mubarack | Citi |
Bert Hazlett | BTIG |
Luke Herrmann | Baird |
Michael Higgins | Ladenburg Thalmann |
Good day, ladies and gentlemen, and welcome to the Eiger BioPharmaceuticals First Quarter 2022 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this call will be recorded. I would now like to introduce Sarah Mathieson, Senior Vice President of Corporate Affairs at Eiger.